In this bonus episode of 12 Geniuses, I reflect on the day that I lost my faith in humanity. However, I also want to share the best day of my life — and the personal journey to get to the point where I became liberated from hate - and the faith returned.
Read MoreHost Don MacPherson is joined by New York City Commissioner for International Affairs, Penny Abeywardena. They explore the future of cities including the impact of COVID-19, combating inequality, and addressing climate change. They also discuss the idea of broadband as a utility and the great steps taken to educate schoolchildren from home.
Read MoreIn this interview, Don MacPherson is joined by Hank Greely, a specialist in the ethical, legal, and social implications of new biomedical technologies. They discuss the roles CRISPR, preimplantation genetic diagnosis (PGD), and in vitro fertilization will have on the future of reproduction. They also discuss the ethical questions that will accompany selecting specific characteristics for implanted embryos and the possibility of creating babies with superhuman capabilities.
Hank Greely specializes in the ethical, legal, and social implications of new biomedical technologies, particularly those related to neuroscience, genetics, or stem cell research. Hank is a genetics professor at the Stanford School of Medicine, the Director of the Center for Law and the Biosciences, and the Chair of the Steering Committee of the Center for Biomedical Ethics.
Read MoreThere is something beautiful about selflessness. With a simple gesture, a little kindness, or an act of generosity, we can make the world a better place. This is a four-minute story of someone who exemplified the spirit of giving and never cared that no one was watching.
Read MoreA decade from now when we look back at what we’ve overcome, we will remember the connections who helped us through this moment and the meaning that gave us the will to endure and the power to persevere.
Read MoreThis week’s Leadership Moment - Leaders at Home
Dark, dusty, and dangerous. Those are the words that could have described the Soudan Iron Mine in Northern Minnesota during its operation. Each day workers would take elevators thousands of feet below the surface of the earth to roam the 54 miles of tunnels and mine its rich veins. My grandfather was one of those workers.
When she was an adult, and after my grandfather had retired, my mom toured the mine. At one point, the tour guide extinguished his light putting Mom and the other tour members in complete darkness. She wept. It was at that moment that she realized the full extent of what her father was willing to do to make her life possible.
Listen to the episode to hear how great leaders continue to inspire us outside the workplace.
Read MoreA generation ago, a cancer diagnosis meant the patient had a 50% chance of living beyond five years. Today, cancer is still an awful disease, but thanks to incredible medical advances, survival is far more likely than ever before. That’s not the only good news. In fact, there is hope that as soon as a decade from now, cancer could possibly be a managed disease instead of a killer.
In this episode, pharmaceutical expert and cancer researcher, Sara Kenkare-Mitra, shares her how she got into the pharmaceutical field, the long road to creating an effective drug, and the importance of celebrating failure.
Sara discusses:
Part One: The Road to Making a Drug
Growing up in India, moving from India to the United States, culture shock, building resilience, joining Genentech, becoming a leader, how her leadership skills as a manager needed to evolve to lead a team of 550 people, the importance of technical competence in a large organization, the drug development process.
Part Two: Curing Cancer
Why it’s good to celebrate failure, how pharmaceutical companies are curing cancer, advice for young women entering STEM fields, encouraging your teams to learn from failures, meditation and leadership, overcoming the minority effect, advocating for yourself, how being a mother made her a more effective leader, the future of cancer, the role of empathy in leadership and drug development.
Organizations, People, Resources, Places Mentioned.
Mumbai, India, Genentech, Austin, Texas, University of Texas - Austin, UCSF (University of California, San Francisco), San Francisco, Kadcyla (Her2+ Breast cancer drug), the FDA (U.S. Food & Drug Administration)
To learn more about Sara and Genentech, please visit www.Gene.com.
Read More